Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Income from Continuing Operations: 2015-2025

Historic Income from Continuing Operations for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$19.8 million.

  • AC Immune's Income from Continuing Operations fell 412.11% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.1 million, marking a year-over-year decrease of 92.76%. This contributed to the annual value of -$58.1 million for FY2024, which is 4.94% up from last year.
  • Per AC Immune's latest filing, its Income from Continuing Operations stood at -$19.8 million for Q3 2025, which was up 27.94% from -$27.5 million recorded in Q2 2025.
  • AC Immune's Income from Continuing Operations' 5-year high stood at $6.4 million during Q3 2024, with a 5-year trough of -$28.4 million in Q4 2021.
  • Its 3-year average for Income from Continuing Operations is -$16.9 million, with a median of -$18.7 million in 2023.
  • In the last 5 years, AC Immune's Income from Continuing Operations surged by 137.06% in 2024 and then plummeted by 412.11% in 2025.
  • Over the past 5 years, AC Immune's Income from Continuing Operations (Quarterly) stood at -$28.4 million in 2021, then spiked by 31.50% to -$19.5 million in 2022, then surged by 72.45% to -$5.4 million in 2023, then tumbled by 235.84% to -$18.0 million in 2024, then slumped by 412.11% to -$19.8 million in 2025.
  • Its Income from Continuing Operations was -$19.8 million in Q3 2025, compared to -$27.5 million in Q2 2025 and -$20.8 million in Q1 2025.